Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2008

01.12.2008 | Research Article

The DARTS tool for assessing online medicines information

verfasst von: Ulla Närhi, Marika Pohjanoksa-Mäntylä, Anna Karjalainen, Johanna K. Saari, Hannes Wahlroos, Marja S. Airaksinen, Simon J. Bell

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective The use of the Internet as a source of medicines information is increasing. However, the quality of online information is highly variable. Equipping Internet users to distinguish good quality information is the aim of a new five-item quality assessment tool (DARTS) that was developed by the Working Group on Information to Patients under the Pharmaceutical Forum established by the European Commission. The objective of this study was to investigate how people with depression assess the quality of online medicines information and to study their opinions about the DARTS tool in assisting in this process. Setting Focus group discussions with Internet users were conducted in metropolitan Helsinki, Finland. Method Six focus group discussions (67–109 min duration) were conducted with people with depression (n = 29). The DARTS tool was used as a stimulus after open discussion in relation to the evaluation of the quality of Internet-based medicines information. The focus groups were digitally audiotaped and transcribed verbatim. The transcripts were thematically content analysed by two researchers. Results Focus group participants were generally critical of the information they retrieved. However, few participants systematically applied quality assessment criteria when retrieving online information. No participants had knowledge or experience of any quality assessment tools. The DARTS tool was perceived as being concise and easy to use and understand. Many participants indicated it would allay some of their concerns related to information quality and act as a reminder. While several participants felt the tool should not be any more extensive, some of them believed it should include a more in-depth explanation to accompany each of the quality criteria. Conclusions The DARTS tool may act as a prompt for people with depression to assess the quality of online information they obtain. The five DARTS criteria may form the basis of a systematic approach to quality assessment and the tool may also act as a reminder of quality issues in general. Further studies are needed to assess the actual value of the DARTS tool as well as its value in relation to other quality assessment instruments.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Andreassen HK, Bujnowska-Fedak MM, Chronaki CE, Dumitru RC, Pudule I, Santana S, et al. European citizens’ use of E-health services: a study of seven countries. BMC Public Health. 2007;7:53. doi:10.1186/1471-2458-7-53.PubMedCrossRef Andreassen HK, Bujnowska-Fedak MM, Chronaki CE, Dumitru RC, Pudule I, Santana S, et al. European citizens’ use of E-health services: a study of seven countries. BMC Public Health. 2007;7:53. doi:10.​1186/​1471-2458-7-53.PubMedCrossRef
6.
Zurück zum Zitat Morahan-Martin JA. How do internet users find, evaluate, and use online health information: a cross-cultural review. Cyber Behav. 2004;7:497–510. Morahan-Martin JA. How do internet users find, evaluate, and use online health information: a cross-cultural review. Cyber Behav. 2004;7:497–510.
9.
Zurück zum Zitat Wagner TH, Baker LC, Bundorf K, Singer S. Use of the internet for health information by the chronically ill. Prev Chronic Dis. 2004;1:A13.PubMed Wagner TH, Baker LC, Bundorf K, Singer S. Use of the internet for health information by the chronically ill. Prev Chronic Dis. 2004;1:A13.PubMed
10.
Zurück zum Zitat Bansil P, Keenan NL, Zlot AI, Gilliland JC. Health-related information on the Web: results from the Healthstyles Survey 2002–2003. Prev Chronic Dis. 2006;3:A36.PubMed Bansil P, Keenan NL, Zlot AI, Gilliland JC. Health-related information on the Web: results from the Healthstyles Survey 2002–2003. Prev Chronic Dis. 2006;3:A36.PubMed
12.
Zurück zum Zitat Pohjanoksa-Mäntylä M, Antila J, Eerikäinen S, Enäkoski M, Hannuksela O, Pietilä K, et al. Utilization of a community pharmacy operated national drug information call-center in Finland. Res Soc Adm Pharm. 2008;4:144–52. doi:10.1016/j.sapharm.2007.05.001. Pohjanoksa-Mäntylä M, Antila J, Eerikäinen S, Enäkoski M, Hannuksela O, Pietilä K, et al. Utilization of a community pharmacy operated national drug information call-center in Finland. Res Soc Adm Pharm. 2008;4:144–52. doi:10.​1016/​j.​sapharm.​2007.​05.​001.
13.
Zurück zum Zitat Bell S, McLachlan AJ, Aslani P, Whitehead P, Chen TF. Community pharmacy services to optimize the use of medications for mental illness: a systematic review. Aust NZ Health Policy. 2005;2:29. doi:10.1186/1743-8462-2-29.CrossRef Bell S, McLachlan AJ, Aslani P, Whitehead P, Chen TF. Community pharmacy services to optimize the use of medications for mental illness: a systematic review. Aust NZ Health Policy. 2005;2:29. doi:10.​1186/​1743-8462-2-29.CrossRef
16.
Zurück zum Zitat Christensen H, Griffiths KM. The prevention of depression using the Internet. Med J Aust. 2002;177(Suppl):S122–5.PubMed Christensen H, Griffiths KM. The prevention of depression using the Internet. Med J Aust. 2002;177(Suppl):S122–5.PubMed
24.
Zurück zum Zitat Kitzinger J. Qualitative research: introducing focus groups. BMJ. 1995;311:299–302.PubMed Kitzinger J. Qualitative research: introducing focus groups. BMJ. 1995;311:299–302.PubMed
25.
Zurück zum Zitat Pohjanoksa-Mäntylä M, Saari JK, Närhi U, Karjalainen A, Pylkkänen K, Airaksinen MS, et al. How and why people with depression access and utilize online drug information: a qualitative study. J Affect Disord. In press. Pohjanoksa-Mäntylä M, Saari JK, Närhi U, Karjalainen A, Pylkkänen K, Airaksinen MS, et al. How and why people with depression access and utilize online drug information: a qualitative study. J Affect Disord. In press.
27.
32.
Zurück zum Zitat Närhi U. Sources of medicine information and their reliability evaluated by medicine users. Pharm World Sci. 2007;29:688–94.PubMedCrossRef Närhi U. Sources of medicine information and their reliability evaluated by medicine users. Pharm World Sci. 2007;29:688–94.PubMedCrossRef
38.
42.
Zurück zum Zitat Eysenbach G, Thomson M. The FA4CT algorithm: a new model and tool for consumers to assess and filter health information on the Internet. Stud Health Technol Inform. 2007;129:142–6.PubMed Eysenbach G, Thomson M. The FA4CT algorithm: a new model and tool for consumers to assess and filter health information on the Internet. Stud Health Technol Inform. 2007;129:142–6.PubMed
43.
Zurück zum Zitat Childs S. Developing health website quality assessment guidelines for the voluntary sector: outcomes from the Judge Project. Health Info Libr J 2004, 21(Suppl 2):14–26 Childs S. Developing health website quality assessment guidelines for the voluntary sector: outcomes from the Judge Project. Health Info Libr J 2004, 21(Suppl 2):14–26
48.
Zurück zum Zitat Ademiluyi G, Rees C, Sheard C. Evaluating the reliability and validity of three tools to assess the quality of health information on the Internet. Patient Educ Couns. 2003;50:151–5.PubMed Ademiluyi G, Rees C, Sheard C. Evaluating the reliability and validity of three tools to assess the quality of health information on the Internet. Patient Educ Couns. 2003;50:151–5.PubMed
49.
Zurück zum Zitat Crawford MJ, Rutter D. Are the views of members of mental health user groups representative of those ‘ordinary’ patients? A cross-sectional survey of services users and providers. J Ment Health. 2004;13:561–8. doi:10.1080/09638230400017111.CrossRef Crawford MJ, Rutter D. Are the views of members of mental health user groups representative of those ‘ordinary’ patients? A cross-sectional survey of services users and providers. J Ment Health. 2004;13:561–8. doi:10.​1080/​0963823040001711​1.CrossRef
51.
Zurück zum Zitat Pirkola SP, Isometsä E, Suvisaari J, Aro S, Joukamaa MJ, Poikolainen K, et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population. Soc Psychiatry Psychiatr Epidemiol. 2005;40:1–10. doi:10.1007/s00127-005-0848-7.PubMedCrossRef Pirkola SP, Isometsä E, Suvisaari J, Aro S, Joukamaa MJ, Poikolainen K, et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population. Soc Psychiatry Psychiatr Epidemiol. 2005;40:1–10. doi:10.​1007/​s00127-005-0848-7.PubMedCrossRef
Metadaten
Titel
The DARTS tool for assessing online medicines information
verfasst von
Ulla Närhi
Marika Pohjanoksa-Mäntylä
Anna Karjalainen
Johanna K. Saari
Hannes Wahlroos
Marja S. Airaksinen
Simon J. Bell
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2008
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9249-9

Weitere Artikel der Ausgabe 6/2008

International Journal of Clinical Pharmacy 6/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.